参考文献/References:
[1] Rikhtegar R,Pezeshkian M,Dolati S,et al. Stem cells as therapy for heart disease:iPSCs,ESCs,CSCs,and skeletal myoblasts[J]. Biomed Pharmacother,2019,109:304-313.
[2] Ernst P,Bidwell PA,Dora M,et al. Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes:implications for disease modeling and maturation[J]. Front Cell Dev Biol,2022,10:986107.
[3] G?hwiler EKN,Motta SE,Martin M,et al. Human iPSCs and genome editing technologies for precision cardiovascular tissue engineering[J]. Front Cell Dev Biol,2021,9:639699.
[4] Narazaki G,Uosaki H,Teranishi M,et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells[J]. Circulation,2008,118(5):498-506.
[5] Burridge PW,Matsa E,Shukla P,et al. Chemically defined generation of human cardiomyocytes[J]. Nat Methods,2014,11(8):855-860.
[6] Lyra-Leite DM,Gutiérrez-Gutiérrez ?,Wang M,et al. A review of protocols for human iPSC culture,cardiac differentiation,subtype-specification,maturation,and?direct reprogramming[J]. STAR Protoc,2022,3(3):101560.
[7] Stiefbold M,Zhang H,Wan LQ. Engineered platforms for mimicking cardiac development and drug screening[J]. Cell Mol Life Sci,2024,81(1):197.
[8] Blazeski A,Zhu R,Hunter DW,et al. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells[J]. Prog Biophys Mol Biol,2012,110(2-3):178-195.
[9] Protze SI,Liu J,Nussinovitch U,et al. Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker[J]. Nat Biotechnol,2017,35(1):56-68.
[10] Liu F,Fang Y,Hou X,et al. Enrichment differentiation of human induced pluripotent stem cells into sinoatrial node-like cells by combined modulation of BMP,FGF,and RA signaling pathways[J]. Stem Cell Res Ther,2020,11(1):284.
[11] Cai Z,Zhu M,Xu L,et al. Directed differentiation of human induced pluripotent stem cells to heart valve cells[J]. Circulation,2024,149(18):1435-1456.
[12] Silva AC,Matthys OB,Joy DA,et al. Co-emergence of cardiac and gut tissues promotes cardiomyocyte maturation within human iPSC-derived organoids[J]. Cell Stem Cell,2021,28(12):2137-2152.e6.
[13] Wickramasinghe NM,Sachs D,Shewale B,et al. PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes[J]. Cell Stem Cell,2022,29(4):559-576.e7.
[14] Fan X,Cyganek L,Nitschke K,et al. Functional characterization of human induced pluripotent stem cell-derived endothelial cells[J]. Int J Mol Sci,2022,23(15):8507.
[15] Wang K,Lin RZ,Hong X,et al. Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA[J]. Sci Adv,2020,6(30):eaba7606.
[16] Foreman KL,Shusta EV,Palecek SP. Defined differentiation of human pluripotent stem cells to brain microvascular endothelial-like cells for modeling the blood-brain barrier[J]. Methods Mol Biol,2023,2683:113-133.
[17] Romagnuolo R,Masoudpour H,Porta-Sánchez A,et al. Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias[J]. Stem Cell Reports,2019,12(5):967-981.
[18] Laflamme MA,Chen KY,Naumova AV,et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts[J]. Nat Biotechnol,2007,25(9):1015-1024.
[19] Gibbs CE,Marchianó S,Zhang K,et al. Graft-host coupling changes can lead to engraftment arrhythmia:a computational study[J]. J Physiol,2023,601(13):2733-2749.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(11):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(11):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(11):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(11):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(11):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(11):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]